Sign in
4

Changes in Ownership

Tempest Therapeutics, Inc. Filed Acc 0001209191-24-001038

Options or other derivatives

  • Chief Medical Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Whiting Samuel Chief Medical Officer 2024-01-03 Grant or award · Employee Stock Option (right to buy) +100,000 100,000 D
Loading xslF345X05/doc4.xml…